{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:46:30Z","timestamp":1792089990057,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Oesophageal cancer (OEC) treated with neoadjuvant chemoradiotherapy (CRT) followed by oesophagectomy is associated with muscle loss and impaired recovery. We aim to evaluate whether a goal-directed nutritional support protocol (GDNS) is associated with muscle loss and improved survival after CRT and oesophagectomy compared with usual care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adults with OEC undergoing CRT and oesophagectomy were included. In this trial, a tertiary centre provided GDNS, and a secondary hospital offered usual care. Changes in appendicular skeletal muscle index (ASMI) were assessed during CRT and up to 12\u00a0months postoperatively using bioelectrical impedance analysis. One-year overall and disease-free survival were investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      GDNS and usual care each included 50 patients. Between baseline and CRT completion, ASMI declined in GDNS (-2.53\u2009\u00b1\u20093.43%) and usual care (-3.20\u2009\u00b1\u20096.92%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.559), recovered between CRT completion and preoperatively (0.95\u2009\u00b1\u20094.33 vs 2.51\u2009\u00b1\u20097.95%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.368; respectively), and declined 12-months postoperatively (-5.75\u2009\u00b1\u20094.75% vs\u00a0-7.09\u2009\u00b1\u20097.38%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.598; respectively). Results remained non- significant after adjustment for confounders and time\u2009\u00d7\u2009group interaction. Survival did not differ between groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In both GDNS and usual care, ASMI declines during CRT, recovers after, and decreases postoperatively. The magnitude of ASMI loss is smaller with GDNS than with usual care, although not statistically significant. Survival does not differ between groups. Our findings underscore the need for personalised, integrated interventions to optimise recovery, particularly in the postoperative phase.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-026-11153-4","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:17:39Z","timestamp":1788452259000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Goal-directed nutritional support in preserving muscle mass and optimising recovery in treatment of oesophageal cancer: results of a prospective non-randomised cluster trial"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1001-0598","authenticated-orcid":false,"given":"Iris","family":"Barth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Stelwagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7199-9873","authenticated-orcid":false,"given":"Linda B. M.","family":"Weerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorienke Gort-van","family":"Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Meinders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milos","family":"Milovanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5272-7565","authenticated-orcid":false,"given":"Jan Willem","family":"Haveman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7338-2818","authenticated-orcid":false,"given":"Marc J.","family":"van Det","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4563-7462","authenticated-orcid":false,"given":"Gerard","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8111-6026","authenticated-orcid":false,"given":"Marjo J. E.","family":"Campmans-Kuijpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"issue":"1","key":"11153_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","volume":"159","author":"M Arnold","year":"2020","unstructured":"Arnold M, Abnet CC, Neale RE et al (2020) Global burden of 5 major types of gastrointestinal cancer. Gastroenterology 159(1):335-349.e15. https:\/\/doi.org\/10.1053\/j.gastro.2020.02.068","journal-title":"Gastroenterology"},{"issue":"22","key":"11153_CR2","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P Van Hagen","year":"2012","unstructured":"Van Hagen P, Hulshof MC, Van Lanschot JJ et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074\u20132084. https:\/\/doi.org\/10.1056\/NEJMoa1112088","journal-title":"N Engl J Med"},{"key":"11153_CR3","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology for Esophageal and Esophagogastric Junction Cancers. Version 4.2024. 2024. Accessed October 4, 2024. http:\/\/www.nccn.org\/guidelines"},{"issue":"9","key":"11153_CR4","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","volume":"16","author":"J Shapiro","year":"2015","unstructured":"Shapiro J, van Lanschot JJ, Hulshof MC et al (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgeryalone for oesophageal or junctional cancer (CROSS): Long-term results of a randomised controlled trial. Lancet Oncol 16(9):1090\u20131098. https:\/\/doi.org\/10.1016\/S1470-2045(15)00040-6","journal-title":"Lancet Oncol"},{"issue":"5","key":"11153_CR5","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1001\/jamasurg.2021.0133","volume":"156","author":"H Wang","year":"2021","unstructured":"Wang H, Tang H, Fang Y et al (2021) Morbidity and mortality of patients who underwent minimally invasive esophagectomy after neoadjuvant chemoradiotherapy vs neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma: a randomized clinical trial. JAMA Surg 156(5):444\u2013451. https:\/\/doi.org\/10.1001\/jamasurg.2021.0133","journal-title":"JAMA Surg"},{"issue":"4","key":"11153_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/nejmoa2409408","volume":"392","author":"J Hoeppner","year":"2025","unstructured":"Hoeppner J, Brunner T, Schmoor C et al (2025) Perioperative chemotherapy or preoperative chemoradiotherapy in esophageal cancer. N Engl J Med 392(4):323\u2013335. https:\/\/doi.org\/10.1056\/nejmoa2409408","journal-title":"N Engl J Med"},{"key":"11153_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153667","author":"KC Banks","year":"2022","unstructured":"Banks KC, Hsu DS, Velotta JB (2022) Outcomes of minimally invasive and robot-assisted esophagectomy for esophageal cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14153667","journal-title":"Cancers (Basel)"},{"issue":"3","key":"11153_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ncponc0112","volume":"2","author":"A Laviano","year":"2005","unstructured":"Laviano A, Meguid MM, Inui A, Muscaritoli M, Rossi-Fanelli F (2005) Therapy insight: Cancer anorexia-cachexia syndrome - When all you can eat is yourself. Nat Clin Pract Oncol 2(3):158\u2013165. https:\/\/doi.org\/10.1038\/ncponc0112","journal-title":"Nat Clin Pract Oncol"},{"issue":"1","key":"11153_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12893-023-02149-6","volume":"23","author":"A Park","year":"2023","unstructured":"Park A, Orlandini MF, Szor DJ, Junior UR, Tustumi F (2023) The impact of sarcopenia on esophagectomy for cancer: a systematic review and meta-analysis. BMC Surg 23(1):240. https:\/\/doi.org\/10.1186\/s12893-023-02149-6","journal-title":"BMC Surg"},{"issue":"12","key":"11153_CR10","doi-asserted-by":"publisher","first-page":"965848","DOI":"10.3389\/fonc.2022.965848","volume":"29","author":"T Xu","year":"2022","unstructured":"Xu T, Li Z, Li H et al (2022) Dynamic changes in the body composition during chemotherapy for gastrointestinal tumors in the context of active nutrition intervention. Front Oncol 29(12):965848. https:\/\/doi.org\/10.3389\/fonc.2022.965848","journal-title":"Front Oncol"},{"issue":"8","key":"11153_CR11","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.31557\/APJCP.2020.21.8.2315","volume":"21","author":"S Movahed","year":"2020","unstructured":"Movahed S, Norouzy A, Motlagh AG et al (2020) Nutritional status in patients with esophageal cancer receiving chemoradiation and assessing the efficacy of usual care for nutritional managements. Asian Pac J Cancer Prev 21(8):2315\u20132323. https:\/\/doi.org\/10.31557\/APJCP.2020.21.8.2315","journal-title":"Asian Pac J Cancer Prev"},{"issue":"Suppl 5","key":"11153_CR12","doi-asserted-by":"publisher","first-page":"S645","DOI":"10.21037\/jtd.2018.11.33","volume":"11","author":"E Steenhagen","year":"2019","unstructured":"Steenhagen E (2019) Preoperative nutritional optimization of esophageal cancer patients. J Thorac Dis 11(Suppl 5):S645\u2013S653. https:\/\/doi.org\/10.21037\/jtd.2018.11.33","journal-title":"J Thorac Dis"},{"issue":"2","key":"11153_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377\u2013381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform"},{"issue":"4","key":"11153_CR14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.clnu.2014.07.010","volume":"34","author":"G Sergi","year":"2015","unstructured":"Sergi G, De Rui M, Veronese N et al (2015) Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living Caucasian older adults. Clin Nutr 34(4):667\u2013673. https:\/\/doi.org\/10.1016\/j.clnu.2014.07.010","journal-title":"Clin Nutr"},{"issue":"4","key":"11153_CR15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(4):601. https:\/\/doi.org\/10.1093\/ageing\/afy169","journal-title":"Age Ageing"},{"issue":"12","key":"11153_CR16","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","volume":"31","author":"L Martin","year":"2013","unstructured":"Martin L, Birdsell L, MacDonald N et al (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31(12):1539\u20131547. https:\/\/doi.org\/10.1200\/JCO.2012.45.2722","journal-title":"J Clin Oncol"},{"issue":"3","key":"11153_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.clgc.2015.07.015","volume":"14","author":"S Taguchi","year":"2016","unstructured":"Taguchi S, Akamatsu N, Nakagawa T et al (2016) Sarcopenia evaluated using the skeletal muscle index is a significant prognostic factor for metastatic urothelial carcinoma. Clin Genitourin Cancer 14(3):237\u2013243. https:\/\/doi.org\/10.1016\/j.clgc.2015.07.015","journal-title":"Clin Genitourin Cancer"},{"issue":"13\u201314","key":"11153_CR18","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/0959-8049(95)00296-0","volume":"31A","author":"S Kaasa","year":"1995","unstructured":"Kaasa S, Bjordal K, Aaronson N et al (1995) The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. Eur J Cancer 31A(13\u201314):2260\u20132263. https:\/\/doi.org\/10.1016\/0959-8049(95)00296-0","journal-title":"Eur J Cancer"},{"issue":"13","key":"11153_CR19","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1245\/s10434-015-4558-4","volume":"22","author":"KW Reisinger","year":"2015","unstructured":"Reisinger KW, Bosmans JW, Uittenbogaart M et al (2015) Loss of skeletal muscle mass during neoadjuvant chemoradiotherapy predicts postoperative mortality in esophageal cancer surgery. Ann Surg Oncol 22(13):4445\u20134452. https:\/\/doi.org\/10.1245\/s10434-015-4558-4","journal-title":"Ann Surg Oncol"},{"key":"11153_CR20","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. 4.3.3. Accessed December 10, 2024. https:\/\/www.R-project.org\/"},{"issue":"4","key":"11153_CR21","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3390\/cancers12040925","volume":"12","author":"HG Yoon","year":"2020","unstructured":"Yoon HG, Oh D, Ahn YC et al (2020) Prognostic impact of sarcopenia and skeletal muscle loss during neoadjuvant chemoradiotherapy in esophageal cancer. Cancers (Basel) 12(4):925. https:\/\/doi.org\/10.3390\/cancers12040925","journal-title":"Cancers (Basel)"},{"issue":"5","key":"11153_CR22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/ans.15106","volume":"89","author":"SS Yassaie","year":"2019","unstructured":"Yassaie SS, Keane C, French SJH, Al-Herz FAJ, Young MK, Gordon AC (2019) Decreased total psoas muscle area after neoadjuvant therapy is a predictor of increased mortality in patients undergoing oesophageal cancer resection. ANZ J Surg 89(5):515\u2013519. https:\/\/doi.org\/10.1111\/ans.15106","journal-title":"ANZ J Surg"},{"key":"11153_CR23","doi-asserted-by":"publisher","first-page":"106206","DOI":"10.1016\/j.ijsu.2021.106206","volume":"97","author":"P Wang","year":"2022","unstructured":"Wang P, Wang S, Li X et al (2022) Skeletal muscle wasting during neoadjuvant therapy as a prognosticator in patients with esophageal and esophagogastric junction cancer: A systematic review and meta-analysis. Int J Surg 97:106206. https:\/\/doi.org\/10.1016\/j.ijsu.2021.106206","journal-title":"Int J Surg"},{"issue":"12","key":"11153_CR24","doi-asserted-by":"publisher","first-page":"e33335","DOI":"10.1097\/MD.0000000000033335","volume":"102","author":"SA Wang","year":"2023","unstructured":"Wang SA, Li F, Zhu J et al (2023) Multidisciplinary nutritional management improves nutritional and hospitalized outcomes of patients with esophageal cancer undergoing chemoradiotherapy: A randomized control trial. Medicine (Baltimore) 102(12):e33335. https:\/\/doi.org\/10.1097\/MD.0000000000033335","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"11153_CR25","doi-asserted-by":"publisher","first-page":"839516","DOI":"10.3389\/fonc.2022.839516","volume":"25","author":"J Lyu","year":"2022","unstructured":"Lyu J, Shi A, Li T et al (2022) Effects of enteral nutrition on patients with oesophageal carcinoma treated with concurrent chemoradiotherapy: a prospective, multicentre, randomised, controlled study. Front Oncol 25(12):839516. https:\/\/doi.org\/10.3389\/fonc.2022.839516","journal-title":"Front Oncol"},{"issue":"3","key":"11153_CR26","doi-asserted-by":"publisher","first-page":"109575","DOI":"10.1016\/j.ejso.2025.109575","volume":"51","author":"EAE Reijneveld","year":"2025","unstructured":"Reijneveld EAE, Kooij CD, Dronkers JJ, Kingma BF, Stel JMA, Sauer M et al (2025) The course of physical fitness and nutritional status in patients following prehabilitation before esophageal cancer surgery: Results from the PRIOR study. Eur J Surg Oncol 51(3):109575. https:\/\/doi.org\/10.1016\/j.ejso.2025.109575","journal-title":"Eur J Surg Oncol"},{"key":"11153_CR27","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.1016\/j.clnu.2021.01.007","volume":"40","author":"R Kita","year":"2021","unstructured":"Kita R, Miyata H, Sugimura K, Tanaka K, Makino T, Yamashita K et al (2021) Clinical effect of enteral nutrition support during neoadjuvant chemotherapy on the preservation of skeletal muscle mass in patients with esophageal cancer. Clin Nutr 40:4380\u20134385. https:\/\/doi.org\/10.1016\/j.clnu.2021.01.007","journal-title":"Clin Nutr"},{"issue":"1","key":"11153_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s41999-022-00735-0","volume":"14","author":"T Harada","year":"2023","unstructured":"Harada T, Tatematsu N, Ueno J et al (2023) Impact of early postoperative factors on changes in skeletal muscle mass after esophagectomy in older patients with esophageal cancer. Eur Geriatr Med 14(1):203\u2013210. https:\/\/doi.org\/10.1007\/s41999-022-00735-0","journal-title":"Eur Geriatr Med"},{"issue":"5","key":"11153_CR29","doi-asserted-by":"publisher","first-page":"667","DOI":"10.21873\/cdp.10379","volume":"4","author":"J Honke","year":"2024","unstructured":"Honke J, Hiramatsu Y, Mori K et al (2024) Effect of perioperative physical activity on skeletal muscle loss 6 months after esophageal cancer surgery. Cancer Diagn Progn 4(5):667\u2013674. https:\/\/doi.org\/10.21873\/cdp.10379","journal-title":"Cancer Diagn Progn"},{"issue":"12","key":"11153_CR30","doi-asserted-by":"publisher","first-page":"6677","DOI":"10.21873\/anticanres.11278","volume":"36","author":"J Liu","year":"2016","unstructured":"Liu J, Motoyama S, Sato Y et al (2016) Decreased skeletal muscle mass after neoadjuvant therapy correlates with poor prognosis in patients with esophageal cancer. Anticancer Res 36(12):6677\u20136685. https:\/\/doi.org\/10.21873\/anticanres.11278","journal-title":"Anticancer Res"},{"issue":"3","key":"11153_CR31","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/jcsm.12529","volume":"11","author":"LBM Weerink","year":"2020","unstructured":"Weerink LBM, Hoorn A, Leeuwen BL, Bock GH (2020) Low skeletal muscle mass and postoperative morbidity in surgical oncology: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 11(3):636\u2013649. https:\/\/doi.org\/10.1002\/jcsm.12529","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"11153_CR32","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1002\/jcsm.13230","volume":"14","author":"F Pigneur","year":"2023","unstructured":"Pigneur F, Di Palma M, Raynard B et al (2023) Psoas muscle index is not representative of skeletal muscle index for evaluating cancer sarcopenia. J Cachexia Sarcopenia Muscle 14(4):1613\u20131620. https:\/\/doi.org\/10.1002\/jcsm.13230","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"11153_CR33","doi-asserted-by":"publisher","first-page":"110558","DOI":"10.1016\/j.nut.2019.110558","volume":"69","author":"Y Qiu","year":"2020","unstructured":"Qiu Y, You J, Wang K et al (2020) Effect of whole-course nutrition management on patients with esophageal cancer undergoing concurrent chemoradiotherapy: A randomized control trial. Nutrition 69:110558. https:\/\/doi.org\/10.1016\/j.nut.2019.110558","journal-title":"Nutrition"},{"issue":"4","key":"11153_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrad057","volume":"7","author":"A Hiensch","year":"2023","unstructured":"Hiensch A, Steenhagen E, van Vulpen JK et al (2023) Effects of exercise after oesophagectomy on body composition and adequacy of energy and protein intake: PERFECT multicentre randomized controlled trial. BJS Open 7(4):zrad057. https:\/\/doi.org\/10.1093\/bjsopen\/zrad057","journal-title":"BJS Open"},{"issue":"6","key":"11153_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-07780-w","volume":"31","author":"S Wang","year":"2023","unstructured":"Wang S, Dai W, Zhu J, Gao B, Ren W, Chen X (2023) Nasogastric tube feeding improves nutritional status and physical state in esophageal cancer patients during chemoradiotherapy: a retrospective study. Support Care Cancer 31(6):341. https:\/\/doi.org\/10.1007\/s00520-023-07780-w","journal-title":"Support Care Cancer"},{"issue":"2","key":"11153_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00268-018-4786-4","volume":"43","author":"DE Low","year":"2019","unstructured":"Low DE, Allum W, De Manzoni G et al (2019) Guidelines for perioperative care in esophagectomy: enhanced recovery after surgery (ERAS\u00ae) society recommendations. World J Surg 43(2):299\u2013330. https:\/\/doi.org\/10.1007\/s00268-018-4786-4","journal-title":"World J Surg"},{"issue":"19","key":"11153_CR37","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.3390\/cancers15194856","volume":"15","author":"TCM Geraedts","year":"2023","unstructured":"Geraedts TCM, Weijs TJ, Berkelmans GHK et al (2023) Long-term survival associated with direct oral feeding following minimally invasive esophagectomy: results from a randomized controlled trial (NUTRIENT II). Cancers (Basel) 15(19):4856. https:\/\/doi.org\/10.3390\/cancers15194856","journal-title":"Cancers (Basel)"},{"issue":"1","key":"11153_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/SLA.0000000000003278","volume":"271","author":"GHK Berkelmans","year":"2020","unstructured":"Berkelmans GHK, Fransen LFC, Dolmans-Zwartjes ACP et al (2020) Direct oral feeding following minimally invasive esophagectomy (NUTRIENT II trial): an international, multicenter Open-label Randomized Controlled Trial. Ann Surg 271(1):41\u201347. https:\/\/doi.org\/10.1097\/SLA.0000000000003278","journal-title":"Ann Surg"},{"issue":"5","key":"11153_CR39","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","volume":"40","author":"M Muscaritoli","year":"2021","unstructured":"Muscaritoli M, Arends J, Bachmann P et al (2021) ESPEN practical guideline: clinical nutrition in cancer. Clin Nutr 40(5):2898\u20132913. https:\/\/doi.org\/10.1016\/j.clnu.2021.02.005","journal-title":"Clin Nutr"},{"issue":"6","key":"11153_CR40","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/j.clnu.2019.07.028","volume":"39","author":"T Van Soom","year":"2020","unstructured":"Van Soom T, El Bakkali S, Gebruers N, Verbelen H, Tjalma W, van Breda E (2020) The effects of chemotherapy on energy metabolic aspects in cancer patients: A systematic review. Clin Nutr 39(6):1863\u20131877. https:\/\/doi.org\/10.1016\/j.clnu.2019.07.028","journal-title":"Clin Nutr"},{"issue":"6","key":"11153_CR41","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1016\/j.clnu.2018.12.035","volume":"38","author":"S Rattanachaiwong","year":"2019","unstructured":"Rattanachaiwong S, Singer P (2019) Indirect calorimetry as point of care testing. Clin Nutr 38(6):2531\u20132544. https:\/\/doi.org\/10.1016\/j.clnu.2018.12.035","journal-title":"Clin Nutr"},{"issue":"13","key":"11153_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12986-016-0145-3","volume":"24","author":"HM Kruizenga","year":"2016","unstructured":"Kruizenga HM, Hofsteenge GH, Weijs PJM (2016) Predicting resting energy expenditure in underweight, normal weight, overweight, and obese adult hospital patients. Nutr Metab (Lond) 24(13):85. https:\/\/doi.org\/10.1186\/s12986-016-0145-3","journal-title":"Nutr Metab (Lond)"},{"issue":"1","key":"11153_CR43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12957-022-02518-0","volume":"20","author":"K Pather","year":"2022","unstructured":"Pather K, Mobley EM, Guerrier C, Esma R, Kendall H, Awad ZT (2022) Long-term survival outcomes of esophageal cancer after minimally invasive Ivor Lewis esophagectomy. World J Surg Oncol 20(1):50. https:\/\/doi.org\/10.1186\/s12957-022-02518-0","journal-title":"World J Surg Oncol"},{"issue":"2","key":"11153_CR44","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1245\/s10434-020-08857-0","volume":"28","author":"Y Yang","year":"2021","unstructured":"Yang Y, Li B, Hua R et al (2021) Assessment of quality outcomes and learning curve for robot-assisted minimally invasive mckeown esophagectomy. Ann Surg Oncol 28(2):676\u2013684. https:\/\/doi.org\/10.1245\/s10434-020-08857-0","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"11153_CR45","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.3390\/nu13072350","volume":"13","author":"D Gort-van Dijk","year":"2021","unstructured":"Gort-van Dijk D, Weerink LBM, Milovanovic M et al (2021) Bioelectrical impedance analysis and mid-upper arm muscle circumference can be used to detect low muscle mass in clinical practice. Nutrients 13(7):2350. https:\/\/doi.org\/10.3390\/nu13072350","journal-title":"Nutrients"},{"key":"11153_CR46","doi-asserted-by":"publisher","first-page":"102710","DOI":"10.1016\/j.redox.2023.102710","volume":"62","author":"FC Malcomson","year":"2023","unstructured":"Malcomson FC, Mathers JC (2023) Translation of nutrigenomic research for personalised and precision nutrition forcancer prevention and for cancer survivors. Redox Biol 62:102710. https:\/\/doi.org\/10.1016\/j.redox.2023.102710","journal-title":"Redox Biol"},{"issue":"9","key":"11153_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/nu17091567","volume":"17","author":"F Sadeghi","year":"2025","unstructured":"Sadeghi F, Hussey J, Doyle SL (2025) One size doesn\u2019t fit all\u201d: nutrition care needs in esophageal and gastric cancer survivors\u2014a qualitative study. Nutrients 17(9):1567. https:\/\/doi.org\/10.3390\/nu17091567","journal-title":"Nutrients"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11153-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11153-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11153-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:48:12Z","timestamp":1792086492000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11153-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11153"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11153-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Figures and pictograms were created using PowerPoint, BioRender.com, and icons from Flaticon.com.","order":1,"name":"Ethics","label":"Visualisation","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the University Medical Centre Groningen (METc 2016\/348 577 NL57787.042.16).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Marjo JE Campmans-Kuijpers: received speaking fees from Janssen Pharmaceuticals outside of the submitted manuscript. Gerard Dijkstra received a grant from DSM-Firmenich, and speaking fees from Abbvie, Janssen-Cilag, Takeda, and Pfizer outside of the submitted manuscript.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"929"}}